B
BTIG Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
276
Affirm
AFRM
$28.4B
|
LJ
Lance Jessurun
| $87.35 | $10 |
89%
downside
| Sell |
14 Jun ‘23
2 years ago |
|
277
Legend Biotech
LEGN
$6.66B
|
JZ
Justin Zelin
| $36.08 | $90 |
149%
upside
| Buy |
13 Jun ‘23
2 years ago |
|
278
iRhythm Technologies
IRTC
$5.82B
|
MT
Marie Thibault
| $181.05 | $140 |
23%
downside
| Buy |
8 Jun ‘23
2 years ago |
|
279
Annexon
ANNX
$238M
|
TS
Thomas Shrader
| $2.17 | $7 |
223%
upside
| Buy |
25 May ‘23
2 years ago |
|
280
i3 Verticals
IIIV
$730M
|
MV
Matt VanVliet
| $30.58 | $28 |
8%
downside
| Buy |
23 May ‘23
2 years ago |
|
281
Coya Therapeutics
COYA
$105M
|
TS
Thomas Shrader
| $6.27 | $15 |
139%
upside
| Buy |
18 May ‘23
2 years ago |
|
282
Kura Oncology
KURA
$713M
|
JZ
Justin Zelin
| $8.22 | $31 |
277%
upside
| Buy |
17 May ‘23
2 years ago |
|
283
Wheels Up
UP
$1.4B
|
MF
Marvin Fong
| $2 | $25 |
1,150%
upside
| Neutral |
10 May ‘23
2 years ago |
|
284
TaskUs
TASK
$1.63B
|
MV
Matthew Vanvliet
| $18.18 | $23 |
27%
upside
| Buy |
9 May ‘23
2 years ago |
|
|
KREF
285
KKR Real Estate Finance Trust
KREF
$648M
|
SB
Sarah Barcomb
| $9.87 | $12 |
22%
upside
| Buy |
25 Apr ‘23
2 years ago |
|
286
Tactile Systems Technology
TCMD
$300M
|
RZ
Ryan Zimmerman
| $13.46 | $28 |
108%
upside
| Buy |
17 Apr ‘23
2 years ago |
|
287
Masimo
MASI
$8B
|
RZ
Ryan Zimmerman
| $147.19 | $200 |
36%
upside
| Buy |
17 Apr ‘23
2 years ago |
|
288
Insulet
PODD
$24.5B
|
RZ
Ryan Zimmerman
| $348.43 | $350 |
0%
upside
| Buy |
17 Apr ‘23
2 years ago |
|
289
Abbott
ABT
$231B
|
RZ
Ryan Zimmerman
| $132.94 | $130 |
2%
downside
| Buy |
17 Apr ‘23
2 years ago |
|
290
Novo Nordisk
NVO
$245B
|
JZ
Justin Zelin
| $55.23 | $15.50 |
72%
downside
| Buy |
28 Mar ‘23
2 years ago |
|
291
BioAtla
BCAB
$31.5M
|
TS
Thomas Shrader
| $0.5365 | $13 |
2,323%
upside
| Buy |
28 Mar ‘23
2 years ago |
|
292
Exagen
XGN
$213M
|
MM
Mark Massaro
| $9.67 | $5 |
48%
downside
| Buy |
22 Mar ‘23
2 years ago |
|
293
MoonLake Immunotherapeutics
MLTX
$3.77B
|
JH
Julian Harrison
| $59.44 | $36 |
39%
downside
| Buy |
9 Mar ‘23
2 years ago |
|
294
CareDx
CDNA
$736M
|
MM
Mark Massaro
| $13.82 | $25 |
81%
upside
| Buy |
28 Feb ‘23
2 years ago |
|
295
Cars.com
CARS
$835M
|
MF
Marvin Fong
| $13.59 | $23 |
69%
upside
| Buy |
24 Feb ‘23
2 years ago |
|
296
Anavex Life Sciences
AVXL
$807M
|
YZ
Yun Zhong
| $9.40 | $28 |
198%
upside
| Buy |
9 Feb ‘23
2 years ago |
|
297
Lyra Therapeutics
LYRA
$11.3M
|
RH
Robert Hazlett
| $6.85 | $1,000 |
14,499%
upside
| Buy |
7 Feb ‘23
2 years ago |
|
298
Riot Platforms
RIOT
$4.91B
|
GL
Gregory Lewis
| $13.29 | $12 |
10%
downside
| Buy |
27 Jan ‘23
2 years ago |
|
299
Amicus Therapeutics
FOLD
$2.46B
|
YZ
Yun Zhong
| $7.99 | $16 |
100%
upside
| Buy |
18 Jan ‘23
2 years ago |
|
300
Mid-America Apartment Communities
MAA
$17B
|
MG
Michael Gorman
| $145.40 | $175 |
20%
upside
| Buy |
11 Jan ‘23
2 years ago |
|